First Patient Treated With Valiant® Thoracic Stent Graft In Aortic Dissection Trial - Minimally Invasive Procedure May Stabilize Bleeding
Links shared publicly online about this topic.
- 968total visits
First Patient Treated With Valiant® Thoracic Stent Graft In Aortic Dissection Trial - Minimally Invasive Procedure May Stabilize Bleeding
View full resource at medicalnewstoday.com
Tags: Bleeding
Most Recently Shared on August 6, 2010 at 8:05 pm By:
First Patient Treated With Valiant® Thoracic Stent Graft In Aortic Dissection Trial - Minimally Invasive Procedure... http://mnt.to/3H4c
Also Shared By:
Simulated mass casualty drill tests nursing training - San Antonio Express-News
mysanantonio.com — “Students from the Practical Nurse Course (PNC) put their classroom learning to a test in a simulated mass casualty exercise held at Camp Bullis. The scenario played out Feb. 29 with stimulated trauma patients arriving at a mocked remote combat support hospital waiting to be treated by health care specialists in a mass casualty environment. After the completion of the PNC course, the graduates are enable to provide first line trauma care on the battlefield, perform as members of Forward Surgical ” View full resource at mysanantonio.com
Most Recently Shared on April 11, 2012 at 1:31 pm By:
hospital 2020 Health Organization
Simulated mass casualty drill tests nursing training - San Antonio Express-News http://t.co/fWwyLgYz via @mySA
Antipsychotic medication associated with modest heart attack risk in older patients with dementia
medicalxpress.com — “Antipsychotic medication was associated with a modest and time-limited increased risk of myocardial infarction (heart attack) among older patients treated with cholinesterase inhibitors for dementia, according to a study published Online First by Archives of Internal Medicine.” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 7:57 pm By:
Cary Byrd - eDrugSearch.com Health Advocate and Pharma
Antipsychotic medication associated with modest heart attack risk in older patients with dementia http://t.co/3YvEsbV9
Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief
news-medical.net — “For the first time NHS patients in Wales with peripheral nerve pain (known as peripheral neuropathic pain) can be treated with a patch containing capsaicin, which can provide at least 12 weeks pain relief following a single 30- or 60-minute application.” View full resource at news-medical.net
Most Recently Shared on March 25, 2012 at 10:41 pm By:
Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief: For... http://t.co/H3JSSpP7
FDA Approves New GERD Treatment - Physician's First Watch
firstwatch.jwatch.org — “The FDA has approved a new device to treat symptoms of gastroesophageal reflux disease in patients who have not responded to traditional medical therapy. The LINX Reflux Management System is a surgically-placed string of magnetic . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 24, 2012 at 6:05 pm By:
Ves Dimov, M.D. Doctor, Internist, Allergist, and Physician
FDA Approves New GERD Treatment - surgically-placed string of magnetic titanium beads in lower esophageal sphincter http://t.co/2N84SPLu
Aspirin Might Have a Role in Preventing and Treating Cancer - Physician's First Watch
firstwatch.jwatch.org — “Regular aspirin use is associated with lower risks for cancer, death from cancer, and cancer metastasis, according to three meta-analyses in the Lancet and Lancet Oncology. In one, researchers examined patient data in some . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 22, 2012 at 4:37 pm By:
Ves Dimov, M.D. Doctor, Internist, Allergist, and Physician
Regular aspirin use is associated with lower risks for cancer, death from cancer, and cancer metastasis http://t.co/mcBaVPL4
A New Approach to Rheumatoid Arthritis - Dana Foundation
dana.org — “Doctors currently treat rheumatoid arthritis, a crippling autoimmune disease, with an arsenal of drugs that, while often effective, can have serious side effect” View full resource at dana.org
Most Recently Shared on March 21, 2012 at 2:25 pm By:
The Dana Foundation Health Organization
Using a nerve stimulator to treat rheumatoid arthritis http://t.co/vmWluiHC Cerebrum essay by Ulf Andersson & Kevin Tracey
Electroshock: First glimpse of how it works adds clues to depression - latimes.com
latimes.com — “Electroconvulsive therapy, or ECT, has been used to jolt severely and persistently depressed patients from their disabling mood state for more than seven decades. And while the treatment is considered highly effective, psychiatrists and mental health researchers have long scratched their heads over the question of just how the practice works to banish crippling depression, sometimes after just a few sessions.” View full resource at latimes.com
Most Recently Shared on March 20, 2012 at 4:19 pm By:
Michael Britt Psychologist, PhD, and Doctor
Electroshock: First glimpse of how it works adds clues to depression http://t.co/yFmhqm2p
Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer
news-medical.net — “Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 3:46 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer: Jenner... http://t.co/MlO8mmVx
Gene therapy to treat Usher Syndrome
eyedocnews.com — “First Usher Syndrome patients with retinitis pigmentosa to be treated with UshStat gene therapy treatment” View full resource at eyedocnews.com
Most Recently Shared on March 12, 2012 at 10:31 am By:
Dr. Ari Weitzner Ophthalmologist, Physician, and Doctor
Discuss: Can Gene Therapy Help Treat Usher Syndrome Patients with Retinitis Pigmentosa?: Last week, the Foundati... http://t.co/UXQjDBUH
FDA approves first cell-based product to treat oral mucogingival conditions in adults
fda.gov — “The Food and Drug Administration today approved GINTUIT, the first cell-based product made from allogeneic human cells (from a donor unrelated to the patient) and bovine collagen. GINTUIT is indicated for topical (non-submerged) application to a surgically created vascular wound bed in the treatment of mucogingival conditions in adults.” View full resource at fda.gov
Most Recently Shared on March 9, 2012 at 5:38 pm By:
eyeonfda Pharma and Health Lawyer
#FDA approves first cell-based product to treat oral mucogingival conditions in adults http://t.co/UojEEoYI
UC San Diego among first in nation to treat brain cancer with novel viral vector
eurekalert.org — “UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a local San Diego company, Tocagen Inc.” View full resource at eurekalert.org
Most Recently Shared on March 2, 2012 at 3:12 pm By:
UC San Diego among first in nation to treat brain cancer with novel viral vector: (University of California - Sa... http://t.co/WlzV0Kfg
Real Stories: Angel's Journey
healthypets.mercola.com — “Today's Real Story features the story of Angel, a young husky that has been diagnosed with an autoimmune disorder called masticatory myositis.” View full resource at healthypets.mercola.com
Most Recently Shared on February 25, 2012 at 3:15 pm By:
Dr. Karen Becker Health Professional
Welcome to the first in a regular series of real life stories of the patients I’ve had the honor to meet and treat. http://t.co/DN9AaMs7
The Challenges Of Treating Addicts with Borderline Personality Disorder | Addiction Recovery
blogs.psychcentral.com — “Dropout rates among patients with BPD and substance use disorders are high largely because of the difficulties engaging this group in a therapeutic relationship. In one moment, the patient may view the therapist as a much needed source of support. At the first perceived sign of rejection, criticism or disapproval, the therapist becomes an enemy who cannot be trusted.” View full resource at blogs.psychcentral.com
Most Recently Shared on February 8, 2012 at 4:08 pm By:
Peter H Brown Psychologist and Doctor
The Challenges Of Treating Addicts with Borderline Personality ... http://t.co/MIfCj8E5 #borderline
Cystic Fibrosis Drug Wins Approval : Shots - Health Blog : NPR
npr.org — “The Food and Drug Administration approved the first drug that treats cystic fibrosis by addressing an underlying cause of the disease. But the medicine, called Kalydeco, will cost nearly $300,000 a year.” View full resource at npr.org
Most Recently Shared on February 1, 2012 at 3:28 pm By:
New CF drug to be free for all patients making < $150K a year. Will be interesting to see if/how it changes QOL- http://t.co/CyjW8vVj
Early Success in a Human Embryonic Stem Cell Trial to Treat Blindness | Healthland | TIME.com
healthland.time.com — “For the researchers at UCLA's Jules Stein Eye Institute who launched the first-ever study to show that human embryonic stem cells may help reverse patients' disease, the history-making day began at 4:30 a.m.” View full resource at healthland.time.com
Most Recently Shared on January 24, 2012 at 12:41 pm By:
Richard G. Lanzara Health Professional
The first patients to receive embryonic stem cells to treat blindness speak out... - http://t.co/wJD32ylH @TIMEHealthland #health #medicine
Advertisement
Heart Health
@HeartsHealth
MedicalNewsToday: First Patient Treated With Valiant® Thoracic Stent Graft In Aortic: http://bit.ly/dskSUO Full http://bit.ly/dr8hyG
1 year ago...